- Home
- JL vs KLTO Comparison
JL vs KLTO Comparison
Compare JL & KLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JL
- KLTO
- Stock Information
- Founded
- JL 1985
- KLTO 2019
- Country
- JL Hong Kong
- KLTO United States
- Employees
- JL N/A
- KLTO N/A
- Industry
- JL
- KLTO
- Sector
- JL
- KLTO
- Exchange
- JL NYSE
- KLTO NYSE
- Market Cap
- JL 10.1M
- KLTO 8.3M
- IPO Year
- JL 2024
- KLTO N/A
- Fundamental
- Price
- JL $5.31
- KLTO $0.41
- Analyst Decision
- JL
- KLTO
- Analyst Count
- JL 0
- KLTO 0
- Target Price
- JL N/A
- KLTO N/A
- AVG Volume (30 Days)
- JL 65.3K
- KLTO 1.4M
- Earning Date
- JL 07-31-2024
- KLTO 02-15-2025
- Dividend Yield
- JL N/A
- KLTO N/A
- EPS Growth
- JL N/A
- KLTO N/A
- EPS
- JL 0.26
- KLTO N/A
- Revenue
- JL $28,378,669.00
- KLTO N/A
- Revenue This Year
- JL N/A
- KLTO N/A
- Revenue Next Year
- JL N/A
- KLTO N/A
- P/E Ratio
- JL $20.50
- KLTO N/A
- Revenue Growth
- JL N/A
- KLTO N/A
- 52 Week Low
- JL $0.23
- KLTO $0.26
- 52 Week High
- JL $29.95
- KLTO $13.10
- Technical
- Relative Strength Index (RSI)
- JL 71.16
- KLTO N/A
- Support Level
- JL $4.53
- KLTO N/A
- Resistance Level
- JL $6.25
- KLTO N/A
- Average True Range (ATR)
- JL 0.59
- KLTO 0.00
- MACD
- JL 0.04
- KLTO 0.00
- Stochastic Oscillator
- JL 66.78
- KLTO 0.00
About JL J-LONG GROUP LIMITED
J-Long Group Ltd is an established distributor in Hong Kong of reflective and non-reflective garment trims including, among others, heat transfers, fabrics, woven labels and tapes, sewing badges, piping, zipper pullers and drawcords. It also offers a wide range of apparel solution services to cater to its customers' needs for reflective and non-reflective garment trims, ranging from market trend analysis, product design and development and production to quality control.
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders.